Company / R&D per Share
Elanco R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.74
FY2025
5-year range
$0.66 / $0.78
FY2021-FY2025
Trend
+6.4%
vs FY2024
Sector context
#159 of 208
Health Care
What the data says
Elanco's r&d per share of $0.74 is lower than 76% of companies in the Health Care sector (FY2025). R&D per Share has fluctuated over the past 10 years, ranging from $0.66 in FY2023 to $0.91 in FY2016.
Based on SEC 10-K filings.
0.74 in FY2025 with a 5-year CAGR of -3.4%.
Improved from $0.66 to $0.74 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +3.0%
- 5-Year CAGR
- -3.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 208This company $0.74 Sector average $28.82
▼
-97.4% below sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 6.4% year-over-year.
- Ranks #159 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2016.
- Lowest r&d per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.72 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.74 | +6.4% |
| FY2024 | $0.70 | +4.9% |
| FY2023 | $0.66 | -2.0% |
| FY2022 | $0.68 | -13.4% |
| FY2021 | $0.78 | -11.3% |
| FY2020 | $0.88 | +19.4% |
| FY2019 | $0.74 | +9.5% |
| FY2018 | $0.67 | -21.4% |
| FY2017 | $0.86 | -5.3% |
| FY2016 | $0.91 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026